Literature DB >> 10223301

The postvaccination antibody response to influenza virus proteins.

R J Cox1, K A Brokstad.   

Abstract

The radio-immunoblot (RIB) assay was used to examine the antibody response to proteins of the vaccine strains induced after influenza vaccination. Vaccination stimulated an antibody response to the surface glycoproteins (HA and NA) and to the internal antigens (NP and M) of the three vaccine strains. Antibodies were detected to both the monomeric form of the haemagglutinin (HA) and its two subunits HA1 and HA2. In addition, antibody to the monomeric form of NA was detected. A wide range of response patterns was observed to the viral proteins. All three major antibody classes (IgG, IgA and IgM) were induced after vaccination and in the majority of volunteers the antibody reactivity increased one week after vaccination. IgM antibodies had a wider reactivity pattern, recognising proteins and subunits which were not fully processed or slightly degraded. The varied antibody response induced after influenza vaccination reflects the differing infection histories of the volunteers with influenza. We show some of the practical limitations of studying the antibody response to influenza vaccination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223301     DOI: 10.1111/j.1699-0463.1999.tb01556.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  12 in total

1.  Restriction of amino acid change in influenza A virus H3HA: comparison of amino acid changes observed in nature and in vitro.

Authors:  Katsuhisa Nakajima; Eri Nobusawa; Ken Tonegawa; Setsuko Nakajima
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  Heterologous viral protein interactions within licensed seasonal influenza virus vaccines.

Authors:  Marina Koroleva; Frances Batarse; Savannah Moritzky; Carole Henry; Francisco Chaves; Patrick Wilson; Florian Krammer; Katherine Richards; Andrea J Sant
Journal:  NPJ Vaccines       Date:  2020-01-10       Impact factor: 7.344

3.  Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.

Authors:  Douglas R Braucher; Jamie N Henningson; Crystal L Loving; Amy L Vincent; Eun Kim; Julia Steitz; Andrea A Gambotto; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

4.  Specific subtyping of influenza A virus using a recombinant hemagglutinin protein expressed in baculovirus.

Authors:  Shahla Shahsavandi; Ali-Hatef Salmanian; Seyed Ali Ghorashi; Shahin Masoudi; Fatemeh Fotouhi; Mohammad Majid Ebrahimi
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

Review 5.  Structural basis of influenza virus neutralization.

Authors:  Thomas Han; Wayne A Marasco
Journal:  Ann N Y Acad Sci       Date:  2011-01-11       Impact factor: 5.691

6.  A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.

Authors:  Nicole A Karras; Matthew Weeres; Wendy Sessions; Xiyan Xu; Todd Defor; Jo-Anne H Young; Heather Stefanski; Claudio Brunstein; Sarah Cooley; Jeffrey S Miller; Bruce R Blazar; John E Wagner; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-29       Impact factor: 5.742

Review 7.  The human antibody response to influenza A virus infection and vaccination.

Authors:  Florian Krammer
Journal:  Nat Rev Immunol       Date:  2019-06       Impact factor: 53.106

8.  Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library.

Authors:  Angeline P C Lim; Conrad E Z Chan; Steven K K Wong; Annie H Y Chan; Eng Eong Ooi; Brendon J Hanson
Journal:  Virol J       Date:  2008-10-28       Impact factor: 4.099

9.  The priming effect of previous natural pandemic H1N1 infection on the immunogenicity to subsequent 2010-2011 influenza vaccination in children: a prospective cohort study.

Authors:  Eun Kyeong Kang; Byung Wook Eun; Nam Hee Kim; Jung Sub Lim; Jun Ah Lee; Dong Ho Kim
Journal:  BMC Infect Dis       Date:  2016-08-22       Impact factor: 3.090

10.  Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans.

Authors:  K A Richards; S Moritzky; I Shannon; T Fitzgerald; H Yang; A Branche; D J Topham; J J Treanor; J Nayak; Andrea J Sant
Journal:  NPJ Vaccines       Date:  2020-08-26       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.